ROSM Selected to Lead Groundbreaking Clinical Trial for Osteoarthritis: $1M Grant Powers Search for Disease-Reversing Therapy

WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Regenerative Orthopedics & Sports Medicine (ROSM) is proud to announce its selection as a premier clinical site for a pioneering new study aimed at transforming the treatment landscape for Osteoarthritis (OA). Supported by a $1M grant from the...

Read More